World's Best Scientists 2026 revealed!
Giovanni Palladini

Giovanni Palladini

D-Index & Metrics

Medicine

D-Index
80
Citations
24794
World Ranking
17061
National Ranking
685

Overview

Giovanni Palladini is affiliated with the University of Pavia in Italy and has a substantial body of work in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. The scientist's research primarily covers the subfields of Molecular Biology, Genetics, Hematology, Nephrology, and Oncology.

The main topics addressed in Palladini's work include:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments
  • Multiple Myeloma Research and Treatments
  • Drug Transport and Resistance Mechanisms
  • Peptidase Inhibition and Analysis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Chronic Myeloid Leukemia Treatments

Frequent collaborators in Palladini's research include Giampaolo Merlini, Paolo Milani, Mario Nuvolone, Efstathios Kastritis, and Stefan Schönland.

The scientist has published extensively in several venues, notably:

  • Blood
  • Amyloid
  • HemaSphere
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Several recent publications by Giovanni Palladini demonstrate a focus on amyloidosis and associated therapies. Selected papers include:

  • Management of AL amyloidosis in 2020, 2020, Blood
  • Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA, 2020, Blood

Other significant work in related fields includes:

  • Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis, 2021, New England Journal of Medicine
  • Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis, 2020, Journal of Clinical Oncology
  • A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis, 2020, Blood

Best Publications

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

    Giovanni Palladini;Angela Dispenzieri;Morie A. Gertz;Shaji Kumar

  • Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types

    Claudio Rapezzi;Giampaolo Merlini;Candida C. Quarta;Letizia Riva

  • Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis

    Giovanni Palladini;Carlo Campana;Catherine Klersy;Alessandra Balduini

  • A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

    Giovanni Palladini;Ute Hegenbart;Paolo Milani;Christoph Kimmich

  • Systemic immunoglobulin light chain amyloidosis.

    Giampaolo Merlini;Angela Dispenzieri;Vaishali Sanchorawala;Stefan O. Schönland

  • A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

    Ashutosh D. Wechalekar;Stefan O. Schonland;Efstathios Kastritis;Julian D. Gillmore

  • Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

    Giovanni Palladini;Vittorio Perfetti;Laura Obici;Riccardo Caccialanza

  • Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

    R. L. Comenzo;D. Reece;G. Palladini;D. Seldin

  • Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

    Efstathios Kastritis;Giovanni Palladini;Monique C. Minnema;Ashutosh D. Wechalekar

  • A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis.

    Giovanni Palladini;Sajitha Sachchithanantham;Paolo Milani;Julian Gillmore

  • Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

    Giovanni Palladini;Francesca Lavatelli;Francesca Lavatelli;Francesca Lavatelli;Paola Russo;Paola Russo;Paola Russo;Stefano Perlini;Stefano Perlini;Stefano Perlini

  • Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

    Efstathios Kastritis;Ashutosh D. Wechalekar;Meletios A. Dimopoulos;Giampaolo Merlini

  • Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

    Giovanni Palladini;Paola Russo;Tiziana Bosoni;Laura Verga

  • Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.

    Claudio Rapezzi;Candida Cristina Quarta;Laura Obici;Federico Perfetto

  • Clinical aspects of systemic amyloid diseases.

    Laura Obici;Vittorio Perfetti;Giovanni Palladini;Remigio Moratti

  • Systemic light chain amyloidosis: an update for treating physicians.

    Giampaolo Merlini;Ashutosh D. Wechalekar;Giovanni Palladini

  • The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

    Giada Bianchi;Laura Oliva;Paolo Cascio;Niccolò Pengo

  • The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

    Giovanni Palladini;Alessandra Barassi;Catherine Klersy;Rosana Pacciolla

  • The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).

    Giovanni Palladini;Vittorio Perfetti;Stefano Perlini;Laura Obici

Frequent Co-Authors

Catherine Klersy
Catherine Klersy University of Pavia
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg
Marco Paulli
Marco Paulli University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens doors to a wide range of related healthcare degrees and career options that can be pursued online. Many students explore fields such as pharmacy, health information management, medical billing and coding, and advanced nursing to complement or broaden their opportunities in healthcare.

For those interested in pharmaceutical care, an online pharmacy school cost is a crucial factor to consider. Online programs can make this advanced degree more accessible and affordable. If you’re drawn to health data and technology, a him degree online can prepare you for key roles in health information management.

Alternatively, earning a medical coding certification is a practical choice for those seeking fast career entry and flexible remote work. Ambitious nurses can pursue leadership and advanced clinical positions by enrolling in one of the most affordable nurse practitioner programs online.

Exploring these pathways enables students to tailor their medical careers, whether seeking clinical roles or supporting the healthcare system in other essential ways.

Best Scientists Citing Giovanni Palladini

Trending Scientists